LON:SKIN - Integumen Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 0.93 0.00 (0.00 %)
(As of 02/15/2019 04:00 PM ET)
Previous CloseGBX 0.93
Today's RangeGBX 0.92 - GBX 0.94
52-Week RangeGBX 1 - GBX 5.50
Volume215,594 shs
Average Volume41,864 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Integumen Plc, a personal health care company, develops and commercializes a range of products for oral, skin, and wound care markets. The company develops TS1, a disposable tongue vacuum cleaner for professional use in the dental surgery, a tongue gel, and a handle, which turns the tongue vacuum cleaner into a tongue scraper for home use. It also offers Labskin, a 3-dimensional human skin equivalent model for basic and applied skin research, pre-clinical screening, microbial testing, and efficacy studies of personal care products. In addition, the company provides a range of cosmetic skincare products under the Stoer brand; consumer and professional cosmeceutical products under the Visible Youth brand for anti-ageing; and Clarogel, an over-the-counter cosmetic product for the treatment of blemishes. In addition, it offers Wound pHase, a diagnostic tool, which is used in the acidity/alkalinity of the wound; and hydrogel as a dressing for use in the treatment of burns. The company was incorporated in 2016 and is headquartered in Dalkey, Ireland.

Receive SKIN News and Ratings via Email

Sign-up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Household & Personal Products



Sales & Book Value

Annual SalesN/A



OptionableNot Optionable

Integumen (LON:SKIN) Frequently Asked Questions

What is Integumen's stock symbol?

Integumen trades on the London Stock Exchange (LON) under the ticker symbol "SKIN."

Has Integumen been receiving favorable news coverage?

News articles about SKIN stock have trended somewhat positive this week, according to InfoTrie. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Integumen earned a media sentiment score of 1.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the stock's share price in the immediate future.

Who are some of Integumen's key competitors?

Who are Integumen's key executives?

Integumen's management team includes the folowing people:
  • Mr. Christopher Bell, CFO, Company Sec. & Exec. Director
  • Mr. Donald Nicholson, Exec. Director (Age 60)
  • Mr. Gerard James Brandon, CEO & Director (Age 56)
  • Mr. Camillus Gerard Glover, COO & Director (Age 57)
  • Alex Chapman, Head of Labskin Operations

How do I buy shares of Integumen?

Shares of SKIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Integumen's stock price today?

One share of SKIN stock can currently be purchased for approximately GBX 0.93.

What is Integumen's official website?

The official website for Integumen is http://www.integumen.co.uk/.

How can I contact Integumen?

Integumen's mailing address is Dalkey, 19 Railway Road, DUBLIN, YO41 1LZ, Ireland. The company can be reached via phone at +353-1-5373269.

MarketBeat Community Rating for Integumen (LON SKIN)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  16 (Vote Outperform)
Underperform Votes:  18 (Vote Underperform)
Total Votes:  34
MarketBeat's community ratings are surveys of what our community members think about Integumen and other stocks. Vote "Outperform" if you believe SKIN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SKIN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel